First Molecular Non-Prescription, At-Home Test for COVID19

The COVID19 is issued as a global pandemic by the World Health Organization (WHO) that affects the respiratory tract. A handy test or over-the-counter available test to detect the COVID virus will be a valuable tool. The US Food and Drug Administration has issued Emergency Use Authorization(EUA), for the COVID19 test from home.

This is the first molecular test authorized at-home use without a prescription. The product is a molecular nucleic acid amplification test (NAAT) that helps in detecting the SARS-CoV2 in the nostrils.

The diagnostic test which enables detection of nucleic acid from SARS-Co-V-2 in nasal swab specimen collected from sample wand is used for nonprescription home use. This self swabbing test can be used for adults and children over 2 years of age self-test which can be done easily at home. The test called Cue COVID19 test and over the counter use ensures efficiency by providing 100% results from positive samples for those not suffering from COVID symptoms and 96% efficiency for that suffering from COVID19 symptoms

The test package includes the following- Single-use Cue COVID 19 test cartridge, the single-use Cue wand nasal swab, the Cue cartridge reader, and the Cue Health mobile application app which can be downloaded on smartphones. The mobile app requires an individual to create an account and also helps to monitor the prevalence of the COVID19 positive cases by the public health authorities.

To know more about origin, virology of COVID-19, Click here

To know more about emerging themes in COVID-19, Click here

To know more about how WhiteCoats can help you in your professional advancement, visit www.whitecoats.com

Want to set up an online consultation for your practice, Click here

Ref Link: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-authorization-first-molecular-non-prescription-home-test

#Featured